iron bisglycinate

A comparative study was conducted on 120 children with IDA, they attended to outpatient clinic at Menoufia University Hospitals within a period from April to November 2019. All subjects were classified into FeBC Group (30 children received iron bisglycinate), LF Group (30 children received lactoferrin 100 mg), LF with iron Group (30 children received 30% iron saturated lactoferrin) and IPC Group (30 children received iron polymaltose complex with elemental iron of6 mg/kg/day). Serum iron, serum ferritin, transferrin saturation was investigated.The aim of this study was to compare the efficacy of Oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron, and IPC in treatment of IDA.

This study aimed to compare the efficacy of oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron and iron polymaltose complex (IPC) in treatment of iron deficiency anemia. A comparative study was conducted on 120 children with IDA, they attended to outpatient clinic at Menoufia University Hospitals within a period from April to November 2019. All subjects were classified into FeBC Group (30 children received iron bisglycinate), LF Group (30 children received lactoferrin 100 mg), LF with iron Group (30 children received 30% iron saturated lactoferrin) and IPC Group (30 children received iron polymaltose complex with elemental iron of6 mg/kg/day). Serum iron, serum ferritin, transferrin saturation was investigated.

Healthy children with IDA were randomly allocated into 3 groups to receive oral bisglycinate (FeBC), lactoferrin (LF), lactoferrin with iron or IPC. Serum ferritin and serum iron were measured, and changes in serum ferritin and transferrin saturation ratios were also registered.

There is not enough evidence to support the use of iron bisglycinate chelate (FeBC) as a potential treatment for IDA, but this may be evaluated in a follow-up study since it is considered cost effective and safe.

The present study was conducted on 120 children with IDA that attended to outpatient clinic at Menoufia University Hospitals within a period from April to November 2019. All the subjects were classified into FeBC Group (30 children received iron bisglycinate), LF Group (30 children received lactoferrin 100 mg), LF with iron Group (30 children received 30% iron saturated lactoferrin) and IPC Group (30 children received iron polymaltose complex with elemental iron of6 mg/kg/day). Serum iron, serum ferritin, transferrin saturation were investigated.

Oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron and iron polymaltose complex (IPC) are all forms of iron in which the heme has been replaced by another compound. In this study, the efficacy of these different formulations were compared to determine if they were more beneficial than a placebo and if they could correct IDA. OBJECTIVE: To compare the efficacy of Oral iron bisglycinate chelate, lactoferrin, lactoferrin with iron and iron polymaltose complex in treatment of IDA. METHODS: A comparative study was conducted on 120 children with IDA, they attended to outpatient clinic within a period from April to November 2019. Subjects were classified into FeBC Group; LF Group, LF with iron Group; IPC Group. Serum ferritin, serum iron, transferrin saturation were investigated .The primary outcome measure was the difference between the initial value and the final one at 6 months post-treatment evaluation …

The aim of this study was to compare the efficacy of oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron, and iron polymaltose complex (IPC) in treatment of iron deficiency anemia (IDA) among children.

In this study, oral iron bisglycinate chelate was compared with lactoferrin and lactoferrin with iron in treating IDA. Patients were classified into 3 different groups according to their treatment method: we found that oral iron bisglycinate chelate has better efficacy than lactoferrin and IPC in breast milk

The aim of this study was to compare the efficacy of Oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron and iron polymaltose complex (IPC) in treatment of iron deficiency anemia (IDA). A comparative study was conducted on 120 children with IDA, they attended to outpatient clinic at Menoufia University Hospitals within a period from April to November 2019. All subjects were classified into FeBC Group (30 children received iron bisglycinate), LF Group (30 children received lactoferrin 100 mg), LF with iron Group (30 children received 30% iron saturated lactoferrin) and IPC Group (30 children received iron polymaltose complex with elemental iron of6 mg/kg/day). Serum iron, serum ferritin, transferrin saturation was investigated.

The purpose of this study is to analyze efficacy of Oral iron bisglycinate chelate (FeBC), lactoferrin (LF), lactoferrin with iron and iron polymaltose complex (IPC) in treatment of IDA. Methods: a comparative study was conducted on 120 children with IDA, they attended to outpatient clinic at Menoufia University Hospitals within a period from April to November 2019. All subjects were classified into FeBC Group (30 children received iron bisglycinate), LF Group (30 children received lactoferrin 100 mg), LF with iron Group (30 children received 30% iron saturated lactoferrin) and IPC Group

In a comparative study on 120 children with IDA, between April and November 2019, FeBC was significantly higher than IPC and LF in serum iron levels; Lymphocytes were significantly higher in FeBC Group than IPC and LF Groups.

By admin

Leave a Reply

Your email address will not be published.